Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor. Article uri icon

Overview

publication date

  • November 15, 2001

Research

keywords

  • Antimetabolites, Antineoplastic
  • Fluorouracil
  • Oxidoreductases
  • Oxidoreductases Acting on CH-CH Group Donors

Identity

Scopus Document Identifier

  • 0035890826

PubMed ID

  • 11709571

Additional Document Info

volume

  • 19

issue

  • 22